Orbimed Advisors LLC Edgewise Therapeutics, Inc. Transaction History
Orbimed Advisors LLC
- $4.24 Billion
- Q3 2024
A detailed history of Orbimed Advisors LLC transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 15,021,721 shares of EWTX stock, worth $432 Million. This represents 9.45% of its overall portfolio holdings.
Number of Shares
15,021,721
Previous 15,021,721
-0.0%
Holding current value
$432 Million
Previous $271 Million
48.2%
% of portfolio
9.45%
Previous 6.52%
Shares
4 transactions
Others Institutions Holding EWTX
# of Institutions
191Shares Held
100MCall Options Held
2.17MPut Options Held
410K-
Ra Capital Management, L.P. Boston, MA8.91MShares$256 Million3.32% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$173 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY5.84MShares$168 Million1.67% of portfolio
-
Novo Holdings Hellerup, G75.55MShares$160 Million10.36% of portfolio
-
Janus Henderson Group PLC London, X04.56MShares$131 Million0.06% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $1.82B
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...